Medipost Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipost Co Ltd with three other
companies in this sector in South Korea:
Seoulin Bioscience Company Limited
sales of 44.89 billion Korean Won [US$40.18 million]
of which 94%
(22.21 billion Korean Won [US$19.87 million]
of which 52%
was Biotechnology), and
(11.35 billion Korean Won [US$10.16 million]
Medipost Co Ltd reported sales of 28.65 billion Korean Won (US$25.65 million)
December of 2016.
decrease of 23.7%
versus 2015, when the company's sales were 37.57 billion Korean Won.